← Open Payments lookup

JULIA DINNEN: Open Payments

NPI 1831590413 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,887 in 99 payments from 18 companies in 2025. Trend: 2023 $1,694 · 2024 $2,340 · 2025 $1,887

Food & beverage: $1,887
CompanyPaymentsAmount
ABBVIE INC.38$647
Takeda Pharmaceuticals U.S.A., Inc.18$367
Janssen Biotech, Inc.8$164
Gilead Sciences, Inc.5$102
Ardelyx, Inc.4$81
Celltrion USA Inc.3$71
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$71
QOL Medical, LLC3$63
Ipsen Biopharmaceuticals, Inc3$56
PFIZER INC.3$52

Products named: ENTYVIO, RINVOQ, SKYRIZI, LINZESS, TREMFYA, IBSRELA, VEGZELMA, XIFAXAN.

Industry payments across VA — which companies pay providers there.